Synthesis of the four stereoisomers of cyclobutane analogues of phenylalanine in enantiomerically pure form
摘要:
All stereoisomers of 1-amino-2-phenylcyclobutanecarboxylic acid-c(4)Phe-have been synthesized and the series c(n)Phe has thus been completed. The use of two different strategies based on a cyclization reaction, starting from ethyl isocyanoacetate and dialkyl malonate, respectively, gave both cis-c(4)Phe and trans-c(4)Phe in racemic form. HPLC resolution of one of the intermediates using a cellulose-derived chiral stationary phase allowed the isolation of the corresponding enantiomerically pure N-protected amino acids, prepared for incorporation into peptides. The relative stereochemistry of enantiopure compounds has been unambiguously assigned. (c) 2005 Elsevier Ltd. All rights reserved.
Synthesis of the four stereoisomers of cyclobutane analogues of phenylalanine in enantiomerically pure form
摘要:
All stereoisomers of 1-amino-2-phenylcyclobutanecarboxylic acid-c(4)Phe-have been synthesized and the series c(n)Phe has thus been completed. The use of two different strategies based on a cyclization reaction, starting from ethyl isocyanoacetate and dialkyl malonate, respectively, gave both cis-c(4)Phe and trans-c(4)Phe in racemic form. HPLC resolution of one of the intermediates using a cellulose-derived chiral stationary phase allowed the isolation of the corresponding enantiomerically pure N-protected amino acids, prepared for incorporation into peptides. The relative stereochemistry of enantiopure compounds has been unambiguously assigned. (c) 2005 Elsevier Ltd. All rights reserved.
Synthesis of Functionalized Tetrahydropyridines by SnCl
<sub>4</sub>
‐Mediated [4+2] Cycloaddition between Donor–Acceptor Cyclobutanes and Nitriles
作者:David Tong、Jackie Wu、Nathan Bazinski、Donghyun Koo、Naresh Vemula、Brian L. Pagenkopf
DOI:10.1002/chem.201903833
日期:2019.12.2
Cycloadditions of strained carbocycles promoted by Lewis acids are powerful methods to construct heterocyclic frameworks. In fact, the formal [3+2] cycloadditions of donor-acceptor (DA) cyclopropanes with nitriles has seen particular success in synthesis. In this work, we report on the first [4+2] cycloaddition of nitriles with DA cyclobutanes by Lewis acid activation. Tetrahydropyridine derivatives
Synthesis of Hexahydropyridazines by [4 + 2] Cycloaddition of Donor–Acceptor Cyclobutanes and <i>cis</i>-Diazenes
作者:Jackie Wu、Paul Winiarz、Dhwanish Patel、Johanna de Jong、David Tong、Tristan Chidley、Naresh Vemula、Brian L. Pagenkopf
DOI:10.1021/acs.orglett.0c00896
日期:2020.4.17
The GaCl3-catalyzed [4 + 2] cycloaddition between alkoxy- and aryl-activated donor–acceptorcyclobutane diesters and cis-diazene 1a (4-phenyl-1,2,4-triazoline-3,5-dione, PTAD) is disclosed. The reaction provides hexahydropyridazine derivatives as single diastereomers in good to excellent yields in most cases. The structural assignment of the cycloadduct 3b was unambiguously established by single-crystal
DFT calculations guide to unveil the electron push-pull effect in reshaping the polymerizability of non-polymerizable cyclobutane to afford densely functionalized all-carbon main-chain polymers, as well as their degradation to afford alkene derivatives. Successful polymerization conditions consist of Lewis acid, Brønsted base, and a C(sp3)-H initiator, while degradation proceeds with catalytic amount
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors
作者:Makoto Shiozaki、Hiroto Imai、Katsuya Maeda、Tomoya Miura、Katsutaka Yasue、Akira Suma、Masahiro Yokota、Yosuke Ogoshi、Julia Haas、Andrew M. Fryer、Ellen R. Laird、Nicole M. Littmann、Steven W. Andrews、John A. Josey、Takayuki Mimura、Yuichi Shinozaki、Hiromi Yoshiuchi、Takashi Inaba
DOI:10.1016/j.bmcl.2009.08.093
日期:2009.11
A series of 1-sulfonylaminocyclopropanecarboxylates was synthesized as ADAMTS-5 (Aggrecanase-2) inhibitors. After an intensive investigation of the central cyclopropane core including its absolute stereochemistry and substituents, we found compound 22 with an Agg-2 IC(50) = 7.4 nM, the most potent ADAMTS-5 inhibitor reported so far. (c) 2009 Elsevier Ltd. All rights reserved.